Keywords: عامل فاکتور VII واکنش پذیر; Hemophilia A; Factor VIII inhibitor; Inhibitor by passing activity; Activated prothrombin concentrate; Recombinant activated factor VII; Factor VIII; Novel agents; TFPI antagonists; ATIII antagonist; Concizumab; Emicizumab; Alpha 1 antitrypsin;
مقالات ISI عامل فاکتور VII واکنش پذیر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل فاکتور VII واکنش پذیر; OAC; Oral anticoagulant; VKA; Vitamin K antagonist; DOAC; Direct oral anticoagulant; PCC; Prothrombin complex concentrate; 4F-PCC; Four factor PCC; 3F-PCC; Three factor PCC; aPCC; Activated PCC; FFP; Fresh frozen plasma; AF; Atrial fibrillation; TE; Throm
Keywords: عامل فاکتور VII واکنش پذیر; Acquired coagulopathies; Acquired hemophilia A; Hemostatic screening; Neurosurgical procedure; 3D; Three-dimensional; AHA; Acquired hemophilia A; APCC; Activated prothrombin complex concentrate; aPTT; Activated partial thromboplastin time; CT; Computed to
Keywords: عامل فاکتور VII واکنش پذیر; Obstetric hemorrhage; Uterine atony; Transfusion; Fibrinogen; Recombinant activated factor VII; Tranexamic acid; Cell salvage;
Keywords: عامل فاکتور VII واکنش پذیر; deep hypothermia; moderate hypothermia; circulatory arrest; coagulopathy; transfusion; hemiarch replacement; aortic arch surgery; ASA; American Society of Anesthesiologists; CPB; cardiopulmonary bypass; DHCA; deep hypothermic circulatory arrest; DUMC; Duk
Keywords: عامل فاکتور VII واکنش پذیر; BTS; Blood Transfusion Service; CMV; cytomegalovirus; FFP; fresh-frozen plasma; FNH; febrile non-hemolytic; IVIg; intravenous immunoglobulin; LR; leukoreduction/leukoreduced; PCC; prothrombin complex concentrate; PLT; platelets; POC; point-of-care; pRBC;
Keywords: عامل فاکتور VII واکنش پذیر; Recombinant activated factor VII; oral bleeding; full-mouth extraction; chronic lymphocytic leukemia; small lymphocytic lymphomaB-CLL/SLL, B-cell lymphocytic leukemia/small lymphocytic lymphoma; CD, Cluster of differentiation; FFP, Fresh frozen plasma; PL
Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery
Keywords: عامل فاکتور VII واکنش پذیر; prothrombin complex concentrate; cardiac surgery; recombinant activated factor VII; factor IX complex; NovoSeven; Bebulin;
Factor VII and thromboembolism
Keywords: عامل فاکتور VII واکنش پذیر; Recombinant activated factor VII; Thomboembolic events; Safety; NovoSeven®; Haemorrhage;
A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study
Keywords: عامل فاکتور VII واکنش پذیر; bleeding; cardiac surgery; patient blood management; recombinant activated factor VII; safety; AMI; acute myocardial infarction; CT-EXTEM; clotting time in the extrinsic pathway by thromboelastometry; IQR; interquartile range; PCC; prothrombin complex con
Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study
Keywords: عامل فاکتور VII واکنش پذیر; AHA; Acquired haemophilia A; APTT; activated partial thromboplastin time; rFVIIa; recombinant activated factor VII; aPCC; activated prothrombin complex concentrate; PCC; prothrombin complex concentrate; TG; thrombin generation; FVIII; factor VIII; DDAVP;
The use of recombinant activated factor VII in patients with acquired haemophilia
Keywords: عامل فاکتور VII واکنش پذیر; Acquired haemophilia; Observational studies; Recombinant activated factor VII; Registries
Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders
Keywords: عامل فاکتور VII واکنش پذیر; Congenital factor VII deficiency; Glanzmann's thrombasthenia; Glanzmann's Thrombasthenia Registry (GTR); Recombinant activated factor VII; Seven Treatment Evaluation Registry (STER); Surgery
Safety update on the use of recombinant activated factor VII in approved indications
Keywords: عامل فاکتور VII واکنش پذیر; Recombinant activated factor VII; NovoSeven®; Safety; Thrombotic events; Inhibitors
Risque thrombotique des traitements médicamenteux des hémorragies
Keywords: عامل فاکتور VII واکنش پذیر; Hémorragie; Thrombose; Sécurité; Acide tranexamique; Concentré de fibrinogène; Concentré de complexe prothrombinique; Facteur VII activé recombinant; Bleeding; Thrombosis; Safety; Tranexamic acid; Fibrinogen concentrate; Prothrombin complex concent
Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors
Keywords: عامل فاکتور VII واکنش پذیر; Congenital haemophilia with inhibitors; On-demand treatment; Recombinant activated factor VII; Surgery
The effects of recombinant activated factor VII dose on the incidence of thromboembolic events in patients with coagulopathic bleeding
Keywords: عامل فاکتور VII واکنش پذیر; rFVIIa; recombinant activated factor VII; VTE; venous thromboembolism; PE; pulmonary embolism; MI; myocardial infarction; CNS; central nervous system; recombinant activated factor VII; thromboembolism; stroke; coagulopathy; trauma;
A double-blind, randomized, controlled study to explore the efficacy of rFVIIa on intraoperative blood loss and mortality in patients with severe acute pancreatitis
Keywords: عامل فاکتور VII واکنش پذیر; ALI; acute lung injury; AP; acute pancreatitis; APACHE II; Acute Physiology and Chronic Health Evaluation II; CT; computed tomography; DIC; disseminated intravascular coagulation; ICU; intensive care unit; rFVIIa; recombinant activated Factor VII; SAP; se
Rapid Warfarin Reversal in the Setting of Intracranial Hemorrhage: A Comparison of Plasma, Recombinant Activated Factor VII, and Prothrombin Complex Concentrate
Keywords: عامل فاکتور VII واکنش پذیر; Intracranial hemorrhage; Plasma; Prothrombin complex concentrate; Recombinant activated factor vii; Reversal; WarfarinEMR, Electronic medical record; FFP, Fresh-frozen plasma; FVIIa, Activated factor VII; INR, International normalized ratio; PCC, Prothrom
Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect
Keywords: عامل فاکتور VII واکنش پذیر; pdFVII; Plasma-derived factor VII; rFVIIa; Recombinant activated factor VII; FVII; Factor VII; NCA; Non-Compartmental Analysis; OCA; One-Compartmental Analysis; Hb; Hemoglobin; T½; Half-life; Cmax; Peak plasma concentration of a drug after administration
Prediction score for effective bleeding control using recombinant activated factor VII in perioperative nonhemophilic patients
Keywords: عامل فاکتور VII واکنش پذیر; Recombinant activated factor VII; Off-label; Surgery; Mortality; Transfusion; Blood loss
Emerging haemostatic agents and patient blood management
Keywords: عامل فاکتور VII واکنش پذیر; fresh-frozen plasma; solvent–detergent plasma; prothrombin complex concentrate; recombinant activated factor VII; factor VIII-bypassing agent; fibrinogen concentrate; factor XIII concentrate
Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: Haemophilia registry data from the Czech Republic
Keywords: عامل فاکتور VII واکنش پذیر; BU; Bethesda Unit(s); CI; confidence interval; CZK; Czech Koruna; GLM; Generalised Linear Model; pd-aPCC; plasma-derived activated prothrombin complex concentrate; rFVIIa; recombinant activated factor VII; SD; standard deviation; SE; standard deviation; C
Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit
Keywords: عامل فاکتور VII واکنش پذیر; arterial thrombosis; bleeding; haemodilution; prothrombin complex concentrates; recombinant activated factor VII;
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: Clinical and economic outcomes
Keywords: عامل فاکتور VII واکنش پذیر; 16; 37; ICU; intensive care unit; LOS; length of stay; MUSC; Medical University of South Carolina; OR; operating room; PRBC; packed red blood cell; rFVIIa; recombinant activated factor VII; TF; tissue factor;
Esperienza clinica nella gestione dell'emorragia intracranica spontanea in pazienti in terapia con warfarin
Keywords: عامل فاکتور VII واکنش پذیر; Intracranial haemorrhage; Oral anticoagulant therapy; Prothrombin complex concentrate; Fresh frozen plasma; Recombinant activated factor VII;
Patient blood management during cardiac surgery: Do we have enough evidence for clinical practice?
Keywords: عامل فاکتور VII واکنش پذیر; 1; 2; 25; 37; ACS; acute coronary syndrome; ACT; activated clotting time; ANH; acute normovolemic hemodilution; CABG; coronary artery bypass grafting; CPB; cardiopulmonary bypass; HES; hydroxyethyl starch; ICER; incremental cost-effectiveness ratio; ICU;
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines*
Keywords: عامل فاکتور VII واکنش پذیر; ACS; acute coronary syndrome; AT; antithrombin; CABG; coronary artery bypass graft surgery; CI; confidence interval; CPB; cardiopulmonary bypass; ECC; extracorporeal circuit; ECMO; extracorporeal membrane oxygenation; EPO; erythropoietin; FDA; Food and Dr
Treatment of Warfarin-Related Intracranial Hemorrhage: A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII
Keywords: عامل فاکتور VII واکنش پذیر; Intracranial hemorrhage; Prothrombin complex concentrate; Recombinant activated factor VII; WarfarinFFP, Fresh-frozen plasma; ICH, Intracranial hemorrhage; INR, International normalized ratio; PCC, Prothrombin complex concentrate; rFVIIa, Recombinant acti
A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia
Keywords: عامل فاکتور VII واکنش پذیر; Intracerebral hemorrhage; Randomized controlled trial; Recombinant activated factor VII; Meta-analysis; Thromboembolic adverse events
Recombinant Activated Factor VII for Massive Hemoptysis in Patients With Cystic Fibrosis
Keywords: عامل فاکتور VII واکنش پذیر; BAE; bronchial artery embolization; CF; cystic fibrosis; rFVIIa; recombinant activated factor VII; TF; tissue factor;
Recombinant Activated Factor VII in Cardiac Surgery: A Meta-analysis
Keywords: عامل فاکتور VII واکنش پذیر; cardiac surgery; bleeding; recombinant activated factor VII; recombinant factor VII; hemostasis
Eficacia del factor VII recombinante activado en el tratamiento de la hemorragia masiva en el postoperatorio de cirugÃa cardiaca: experiencia en 32 pacientes
Keywords: عامل فاکتور VII واکنش پذیر; CirugÃa cardiaca; Hemorragia; Factor VII recombinante activado; rFVIIa; CoagulopatÃa; Cardiac surgery; Hemorrhage; Recombinant activated factor VII; Coagulation disorder;
Monitoring Recombinant Factor VIIa Treatment: Efficacy Depends on High Levels of Fibrinogen in a Model of Severe Dilutional Coagulopathy
Keywords: عامل فاکتور VII واکنش پذیر; recombinant activated factor VII; fibrinogen concentrate; hemodilution; dilutional coagulopathy; thromboelastography; thromboelastometry; ROTEM; Sonoclot analyzer
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation
Keywords: عامل فاکتور VII واکنش پذیر; Anticoagulation; Warfarin; Prothrombin complex concentrate; Recombinant activated factor VII
Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs
Keywords: عامل فاکتور VII واکنش پذیر; Traumatic brain injury; TBI; rFVIIa; Cerebral contusion; Recombinant Activated Factor VII; Hemostasis; Diffuse axonal injury; Neuroprotection
Advances in the Care of Patients With Intracerebral Hemorrhage
Keywords: عامل فاکتور VII واکنش پذیر; ED; emergency department; FFP; fresh-frozen plasma; ICH; intracerebral hemorrhage; INR; international normalized ratio; PCC; prothrombin complex concentrate; rFVIIa; recombinant activated factor VII; STICH; Surgical Treatment in Intracerebral Haemorrhage;
Factor VIIa recombinante (rFVIIa). Descripción de uso en una cohorte de enfermos crÃticos y marcadores pronósticos
Keywords: عامل فاکتور VII واکنش پذیر; factor VII activado recombinante; marcadores pronósticos; recombinant activated factor VII; prognostic markers;
Factor VII activado recombinante
Keywords: عامل فاکتور VII واکنش پذیر; factor VII; factor VII activo recombinante; hemorragia masiva; coagulopatÃas; factor VII; recombinant activated factor VII; massive bleeding;
Hémorragie de la délivrance « menaçant la vie » et utilisation du facteur VII recombinant activé rFVIIa NovoSeven®
Keywords: عامل فاکتور VII واکنش پذیر; Hémorragie du post-partum; Facteur VII recombinant activé; Postpartum haemorrhage; Recombinant activated factor VII;
Use of recombinant activated factor VII in massive obstetric haemorrhage
Keywords: عامل فاکتور VII واکنش پذیر; Postpartum haemorrhage; Recombinant activated factor VII
Volume and electrolyte management
Keywords: عامل فاکتور VII واکنش پذیر; cerebral perfusion pressure; CBF-targeted therapy; colloid; colloid oncotic pressure; CPP-targeted therapy; crystalloid; haemodilution; hypertonic saline; hypovolaemia; mannitol; osmolality; osmolarity; recombinant activated factor VII
Total Hip Arthroplasty in Severe Congenital Factor VII Deficiency
Keywords: عامل فاکتور VII واکنش پذیر; congenital factor VII deficiency; total hip arthroplasty; recombinant activated factor VII; substitution therapy; hemostasis;
Recombinant FVIIa in children with liver disease
Keywords: عامل فاکتور VII واکنش پذیر; rFVIIa; recombinant activated Factor VII; INR; the international normalized ratio for prothrombin time; FFP; fresh frozen plasma; Child; Gastrointestinal haemorrhage; Haemostasis; Liver diseases; Octreotide; Recombinant factor VIIa (rFVIIa);